{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T22:43:29Z","timestamp":1771022609626,"version":"3.50.1"},"reference-count":114,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,12]],"date-time":"2022-06-12T00:00:00Z","timestamp":1654992000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.ejps.2022.106237","type":"journal-article","created":{"date-parts":[[2022,6,13]],"date-time":"2022-06-13T21:00:44Z","timestamp":1655154044000},"page":"106237","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"special_numbering":"C","title":["The potential use of tetracyclines in neurodegenerative diseases and the role of nano-based drug delivery systems"],"prefix":"10.1016","volume":"175","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3413-7262","authenticated-orcid":false,"given":"Mahdieh","family":"Rahmani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sof\u00eda Elisa","family":"Negro \u00c1lvarez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0566-2367","authenticated-orcid":false,"given":"Emilia Barcia","family":"Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2022.106237_bib0001","doi-asserted-by":"crossref","first-page":"14065","DOI":"10.1038\/s41598-017-14450-5","article-title":"Minocycline modulates microglia polarization in ischemia-reperfusion model of retinal degeneration and induces neuroprotection","volume":"7","author":"Ahmed","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejps.2022.106237_bib0002","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1039\/C0OB00303D","article-title":"Tetracycline prevents A\u03b2 oligomer toxicity through an atypical supramolecular interaction","volume":"9","author":"Airoldi","year":"2011","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.ejps.2022.106237_bib0003","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1016\/j.stemcr.2018.03.024","article-title":"Inducible expression of GDNF in transplanted iPSC-derived neural progenitor cells","volume":"10","author":"Akhtar","year":"2018","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.ejps.2022.106237_bib0004","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/imm.12233","article-title":"Inflammation in neurodegenerative diseases\u2013an update","volume":"142","author":"Amor","year":"2014","journal-title":"Immunology"},{"key":"10.1016\/j.ejps.2022.106237_bib0005","doi-asserted-by":"crossref","first-page":"44","DOI":"10.2174\/138955712798868977","article-title":"Tetracyclines: drugs with huge therapeutic potential","volume":"12","author":"Bahrami","year":"2012","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.ejps.2022.106237_bib0006","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1177\/1352458508099482","article-title":"Matrix metalloproteinase-9 and matrix metalloproteinase-2 as biomarkers of various courses in multiple sclerosis","volume":"15","author":"Benesov\u00e1","year":"2009","journal-title":"Mult. Scler."},{"key":"10.1016\/j.ejps.2022.106237_bib0007","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1086\/597807","article-title":"The antibiotics doxycycline and minocycline inhibit the inflammatory responses to the lyme disease spirochete borrelia burgdorferi","volume":"199","author":"Bernardino","year":"2009","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ejps.2022.106237_bib0008","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1080\/03639045.2017.1291669","article-title":"Nano-carrier mediated co-delivery of methyl prednisolone and minocycline for improved post-traumatic spinal cord injury conditions in rats","volume":"43","author":"Bin","year":"2017","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ejps.2022.106237_bib0009","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1159\/000330363","article-title":"Inhibition of microglial activation protects hippocampal neurogenesis and improves cognitive deficits in a transgenic mouse model for Alzheimer's disease","volume":"9","author":"Biscaro","year":"2012","journal-title":"Neurodegener. Dis."},{"key":"10.1016\/j.ejps.2022.106237_bib0010","first-page":"PA2175","article-title":"Tetracycline alleviates acute lung injury by inhibition of NLRP3 inflammasome","volume":"54","author":"Bode","year":"2019","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.ejps.2022.106237_bib0011","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1111\/bph.15439","article-title":"Doxycycline and its derivative, COL-3, decrease dyskinesia induced by l-DOPA in hemiparkinsonian rats","volume":"178","author":"Bortolanza","year":"2021","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejps.2022.106237_bib0012","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1007\/s00702-018-1913-1","article-title":"Tetracycline repurposing in neurodegeneration: focus on Parkinson's disease","volume":"125","author":"Bortolanza","year":"2018","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.ejps.2022.106237_bib0013","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1093\/brain\/awf133","article-title":"Targeting leukocyte MMPs and transmigration: minocycline as a potential therapy for multiple sclerosis","volume":"125","author":"Brundula","year":"2002","journal-title":"Brain"},{"key":"10.1016\/j.ejps.2022.106237_bib0014","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.phrs.2010.05.002","article-title":"\u03b2-Amyloid precursor protein metabolism: focus on the functions and degradation of its intracellular domain","volume":"62","author":"Buoso","year":"2010","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejps.2022.106237_bib0015","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/j.1365-3083.2005.01649.x","article-title":"Neurotrophic factors and clinical recovery in relapsing-remitting multiple sclerosis","volume":"62","author":"Caggiula","year":"2005","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.ejps.2022.106237_bib0016","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.2147\/CIA.S46536","article-title":"Minocycline alleviates beta-amyloid protein and tau pathology via restraining neuroinflammation induced by diabetic metabolic disorder","volume":"8","author":"Cai","year":"2013","journal-title":"Clin. Interv. Aging"},{"key":"10.1016\/j.ejps.2022.106237_bib0017","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1080\/14737175.2020.1838276","article-title":"Minocycline for the management of multiple sclerosis: repositioning potential, opportunities, and challenges","volume":"21","author":"Chauhan","year":"2021","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.ejps.2022.106237_bib0018","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ejphar.2012.04.043","article-title":"Minocycline up-regulates the expression of brain-derived neurotrophic factor and nerve growth factor in experimental autoimmune encephalomyelitis","volume":"686","author":"Chen","year":"2012","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejps.2022.106237_bib0019","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jneuroim.2011.04.006","article-title":"The prospects of minocycline in multiple sclerosis","volume":"235","author":"Chen","year":"2011","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.ejps.2022.106237_bib0020","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s12640-009-9078-1","article-title":"Doxycycline is neuroprotective against nigral dopaminergic degeneration by a dual mechanism involving MMP-3","volume":"16","author":"Cho","year":"2009","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.ejps.2022.106237_bib0021","doi-asserted-by":"crossref","first-page":"41647","DOI":"10.1074\/jbc.M111.274548","article-title":"Testing the therapeutic potential of doxycycline in a Drosophila melanogaster model of Alzheimer disease","volume":"286","author":"Costa","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejps.2022.106237_bib0022","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1172\/JCI58656","article-title":"The immunology of neurodegeneration","volume":"122","author":"Czirr","year":"2012","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ejps.2022.106237_bib0023","first-page":"442","article-title":"Adeno-associated virus vector integration","volume":"11","author":"Deyle","year":"2009","journal-title":"Curr. Opin. Mol. Ther."},{"key":"10.1016\/j.ejps.2022.106237_bib0024","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/329418","article-title":"Anti-inflammatory properties of low and high doxycycline doses: an in vitro study","volume":"2015","author":"Di Caprio","year":"2015","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.ejps.2022.106237_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2021.105256","article-title":"Doxycycline inhibits \u03b1-synuclein-associated pathologies in vitro and in vivo","volume":"151","author":"Dominguez-Meijide","year":"2021","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ejps.2022.106237_bib0026","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.nano.2017.02.006","article-title":"Regulation of human GDNF gene expression in nigral dopaminergic neurons using a new doxycycline-regulated NTS-polyplex nanoparticle system","volume":"13","author":"Espadas-Alvarez","year":"2017","journal-title":"Nanomedicine"},{"key":"10.1016\/j.ejps.2022.106237_bib0027","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1177\/1352458517728811","article-title":"Unexpected additive effects of minocycline and hydroxychloroquine in models of multiple sclerosis: prospective combination treatment for progressive disease?","volume":"24","author":"Faissner","year":"2018","journal-title":"Mult. Scler."},{"key":"10.1016\/j.ejps.2022.106237_bib0028","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.3390\/cells10082163","article-title":"The chemically-modified tetracycline COL-3 and its parent compound doxycycline prevent microglial inflammatory responses by reducing glucose-mediated oxidative stress","volume":"10","author":"Ferreira Junior","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.ejps.2022.106237_bib0029","doi-asserted-by":"crossref","first-page":"S76","DOI":"10.1016\/j.jalz.2013.12.010","article-title":"Inflammation, defective insulin signaling, and neuronal dysfunction in Alzheimer's disease","volume":"10","author":"Ferreira","year":"2014","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.ejps.2022.106237_bib0030","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2174\/1871526510909010023","article-title":"Tetracyclines and prion infectivity","volume":"9","author":"Forloni","year":"2009","journal-title":"Infect. Disord. Drug Targets"},{"key":"10.1016\/j.ejps.2022.106237_bib0031","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.pnpbp.2017.03.010","article-title":"Minocycline reduces inflammatory parameters in the brain structures and serum and reverses memory impairment caused by the administration of amyloid \u03b2 (1-42) in mice","volume":"77","author":"Garcez","year":"2017","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.ejps.2022.106237_bib0032","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/bph.12139","article-title":"Minocycline: far beyond an antibiotic","volume":"169","author":"Garrido-Mesa","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejps.2022.106237_bib0033","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1074\/jbc.M110.178376","article-title":"Effect of tetracyclines on the dynamics of formation and destructuration of beta2-microglobulin amyloid fibrils","volume":"286","author":"Giorgetti","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejps.2022.106237_bib0034","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1177\/08959374980120010501","article-title":"Tetracyclines inhibit connective tissue breakdown by multiple non-antimicrobial mechanisms","volume":"12","author":"Golub","year":"1998","journal-title":"Adv. Dent. Res."},{"key":"10.1016\/j.ejps.2022.106237_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2022.108999","article-title":"Impact of chronic doxycycline treatment in the APP\/PS1 mouse model of Alzheimer's disease","volume":"209","author":"Gomez-Murcia","year":"2022","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejps.2022.106237_bib0036","doi-asserted-by":"crossref","first-page":"20258","DOI":"10.1038\/s41598-020-76927-0","article-title":"CMT-3 targets different \u03b1-synuclein aggregates mitigating their toxic and inflammogenic effects","volume":"10","author":"Gonz\u00e1lez-Liz\u00e1rraga","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejps.2022.106237_bib0037","doi-asserted-by":"crossref","first-page":"41755","DOI":"10.1038\/srep41755","article-title":"Repurposing doxycycline for synucleinopathies: remodelling of \u03b1-synuclein oligomers towards non-toxic parallel beta-sheet structured species","volume":"7","author":"Gonz\u00e1lez-Liz\u00e1rraga","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejps.2022.106237_bib0038","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1212\/01.WNL.0000125321.92112.7E","article-title":"Placebo-controlled phase I\/II studies of minocycline in amyotrophic lateral sclerosis","volume":"62","author":"Gordon","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.ejps.2022.106237_bib0039","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S1474-4422(07)70270-3","article-title":"Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial","volume":"6","author":"Gordon","year":"2007","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ejps.2022.106237_bib0040","doi-asserted-by":"crossref","first-page":"5547","DOI":"10.1073\/pnas.89.12.5547","article-title":"Tight control of gene expression in mammalian cells by tetracycline-responsive promoters","volume":"89","author":"Gossen","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejps.2022.106237_bib0041","doi-asserted-by":"crossref","first-page":"C539","DOI":"10.1152\/ajpcell.00047.2010","article-title":"Tetracyclines: a pleitropic family of compounds with promising therapeutic properties. Review of the literature","volume":"299","author":"Griffin","year":"2010","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.ejps.2022.106237_bib0042","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1089\/rej.2011.1302","article-title":"Leukocyte CCR2 expression is associated with mini-mental state examination score in older adults","volume":"15","author":"Harries","year":"2012","journal-title":"Rejuvenation Res."},{"key":"10.1016\/j.ejps.2022.106237_bib0043","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/539179a","article-title":"Neurodegenerative diseases","volume":"539","author":"Heemels","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.ejps.2022.106237_bib0044","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nri3705","article-title":"Innate immune activation in neurodegenerative disease","volume":"14","author":"Heneka","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ejps.2022.106237_bib0045","doi-asserted-by":"crossref","first-page":"16755","DOI":"10.1523\/JNEUROSCI.4521-10.2010","article-title":"Reimagining Alzheimer's disease\u2014an age-based hypothesis","volume":"30","author":"Herrup","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejps.2022.106237_bib0046","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12951-020-0585-9","article-title":"Local delivery of minocycline-loaded PLGA nanoparticles from gelatin-coated neural implants attenuates acute brain tissue responses in mice","volume":"18","author":"Holmkvist","year":"2020","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.ejps.2022.106237_bib0047","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1001\/jamaneurol.2019.3762","article-title":"Minocycline at 2 different dosages vs placebo for patients with mild Alzheimer disease: a randomized clinical trial","volume":"77","author":"Howard","year":"2020","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.ejps.2022.106237_bib0048","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s11920-011-0195-1","article-title":"Neurobiology of delusions in Alzheimer's disease","volume":"13","author":"Ismail","year":"2011","journal-title":"Curr. Psychiatry Rep."},{"key":"10.1016\/j.ejps.2022.106237_bib0049","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1523\/JNEUROSCI.22-05-01763.2002","article-title":"Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine mouse model of Parkinson disease","volume":"22","author":"Jackson-Lewis","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejps.2022.106237_bib0050","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1002\/ana.10483","article-title":"Oxidative stress in Parkinson's disease","volume":"53","author":"Jenner","year":"2003","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ejps.2022.106237_bib0051","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","article-title":"Parkinson's disease","volume":"386","author":"Kalia","year":"2015","journal-title":"Lancet North Am. Ed."},{"key":"10.1016\/j.ejps.2022.106237_bib0052","first-page":"221","article-title":"Improved drug loading and antibacterial activity of minocycline-loaded PLGA nanoparticles prepared by solid\/oil\/water ion pairing method","volume":"7","author":"Kashi","year":"2012","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ejps.2022.106237_bib0053","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.expneurol.2010.12.010","article-title":"Treatment with minocycline after disease onset alters astrocyte reactivity and increases microgliosis in SOD1 mutant mice","volume":"228","author":"Keller","year":"2011","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.ejps.2022.106237_bib0054","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1212\/WNL.66.10_suppl_4.S50","article-title":"Issues in neuroprotection clinical trials in Parkinson's disease","volume":"66","author":"Kieburtz","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.ejps.2022.106237_bib0055","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/S0140-6736(10)61156-7","article-title":"Amyotrophic lateral sclerosis","volume":"377","author":"Kiernan","year":"2011","journal-title":"Lancet North Am. Ed."},{"key":"10.1016\/j.ejps.2022.106237_bib0056","doi-asserted-by":"crossref","first-page":"13435","DOI":"10.1523\/JNEUROSCI.3257-09.2009","article-title":"Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord","volume":"29","author":"Kigerl","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejps.2022.106237_bib0057","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/BF00225252","article-title":"Function and induction of the microsomal heme oxygenase","volume":"53-54","author":"Kikuchi","year":"1983","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.ejps.2022.106237_bib0058","doi-asserted-by":"crossref","first-page":"e525","DOI":"10.1038\/cddis.2013.54","article-title":"Minocycline selectively inhibits M1 polarization of microglia","volume":"4","author":"Kobayashi","year":"2013","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejps.2022.106237_bib0059","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1002\/glia.22496","article-title":"Doxycycline restrains glia and confers neuroprotection in a 6-OHDA Parkinson model","volume":"61","author":"Lazzarini","year":"2013","journal-title":"Glia"},{"key":"10.1016\/j.ejps.2022.106237_bib0060","doi-asserted-by":"crossref","first-page":"E7580","DOI":"10.1073\/pnas.1608432113","article-title":"Motor neuron disease, TDP-43 pathology, and memory deficits in mice expressing ALS\u2013FTD-linked <em>UBQLN2<\/em> mutations","volume":"113","author":"Le","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejps.2022.106237_bib0061","doi-asserted-by":"crossref","first-page":"611","DOI":"10.3892\/or.2017.5718","article-title":"Cancer drug delivery in the nano era: an overview and perspectives (Review)","volume":"38","author":"Li","year":"2017","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.ejps.2022.106237_bib0062","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1159\/000325653","article-title":"Non-steroidal anti-inflammatory drug use and the risk of Parkinson's disease","volume":"36","author":"Manthripragada","year":"2011","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.ejps.2022.106237_bib0063","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2017.00064","article-title":"Neuronal mitophagy in neurodegenerative diseases","volume":"10","author":"Martinez-Vicente","year":"2017","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.ejps.2022.106237_bib0064","doi-asserted-by":"crossref","first-page":"4109","DOI":"10.1039\/D0BM00809E","article-title":"Nanomaterial based drug delivery systems for the treatment of neurodegenerative diseases","volume":"8","author":"Masoudi Asil","year":"2020","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.ejps.2022.106237_bib0065","first-page":"70","article-title":"Efficacy of doxycycline as add-on to interferon beta-1a in treatment of multiple sclerosis","volume":"11","author":"Mazdeh","year":"2012","journal-title":"Iran J. Neurol."},{"key":"10.1016\/j.ejps.2022.106237_bib0066","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2165\/00063030-200519010-00004","article-title":"Pharmacologic approaches to the treatment of amyotrophic lateral sclerosis","volume":"19","author":"McGeer","year":"2005","journal-title":"BioDrugs"},{"key":"10.1016\/j.ejps.2022.106237_bib0067","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.635760","article-title":"Doxycycline interferes with tau aggregation and reduces its neuronal toxicity","volume":"13","author":"Medina","year":"2021","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.ejps.2022.106237_bib0068","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1056\/NEJMoa1608889","article-title":"Trial of minocycline in a clinically isolated syndrome of multiple sclerosis","volume":"376","author":"Metz","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejps.2022.106237_bib0069","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1177\/1352458509106779","article-title":"Glatiramer acetate in combination with minocycline in patients with relapsing\u2013remitting multiple sclerosis: results of a Canadian, multicenter, double-blind, placebo-controlled trial","volume":"15","author":"Metz","year":"2009","journal-title":"Mult. Scler."},{"key":"10.1016\/j.ejps.2022.106237_bib0070","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1002\/ana.20111","article-title":"Minocycline reduces gadolinium-enhancing magnetic resonance imaging lesions in multiple sclerosis","volume":"55","author":"Metz","year":"2004","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ejps.2022.106237_bib0071","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/archneurol.2007.41","article-title":"Combination therapy with interferon beta-1a and doxycycline in multiple sclerosis: an open-label trial","volume":"65","author":"Minagar","year":"2008","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.ejps.2022.106237_bib0072","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1002\/mds.10473","article-title":"The unified Parkinson's disease rating scale (UPDRS): status and recommendations","volume":"18","year":"2003","journal-title":"Mov. Disord."},{"key":"10.1016\/j.ejps.2022.106237_bib0073","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ijbiomac.2013.04.011","article-title":"Evaluation of safety and efficacy of brain targeted chitosan nanoparticles of minocycline","volume":"59","author":"Nagpal","year":"2013","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ejps.2022.106237_bib0074","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1248\/cpb.c12-00732","article-title":"Formulation, optimization, in vivo pharmacokinetic, behavioral and biochemical estimations of minocycline loaded chitosan nanoparticles for enhanced brain uptake","volume":"61","author":"Nagpal","year":"2013","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.ejps.2022.106237_bib0075","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2020.00494","article-title":"Nanotechnology: a promising approach for delivery of neuroprotective drugs","volume":"14","author":"Naqvi","year":"2020","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.ejps.2022.106237_bib0076","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/j.1471-4159.2005.03520.x","article-title":"Minocycline exerts inhibitory effects on multiple mitogen-activated protein kinases and I\u03baB\u03b1 degradation in a stimulus-specific manner in microglia","volume":"96","author":"Nikodemova","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejps.2022.106237_bib0077","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1016\/j.mayocp.2018.04.007","article-title":"Amyotrophic lateral sclerosis: an update for 2018","volume":"93","author":"Oskarsson","year":"2018","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.ejps.2022.106237_bib0078","doi-asserted-by":"crossref","first-page":"9881","DOI":"10.1021\/nn4036014","article-title":"Selective nanovector mediated treatment of activated proinflammatory microglia\/macrophages in spinal cord injury","volume":"7","author":"Papa","year":"2013","journal-title":"ACS Nano"},{"issue":"6","key":"10.1016\/j.ejps.2022.106237_bib0079","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.4110\/in.2020.20.e47","article-title":"Immunotherapy of autoimmune diseases with nonantibiotic properties of tetracyclines","volume":"20","author":"Park","year":"2020","journal-title":"Immune Netw."},{"key":"10.1016\/j.ejps.2022.106237_bib0080","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2017.00068","article-title":"ALS Clinical trials review: 20 years of failure. Are we any closer to registering a new treatment?","volume":"9","author":"Petrov","year":"2017","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.ejps.2022.106237_bib0081","doi-asserted-by":"crossref","first-page":"e73422","DOI":"10.1371\/journal.pone.0073422","article-title":"Prolonged minocycline treatment impairs motor neuronal survival and glial function in organotypic rat spinal cord cultures","volume":"8","author":"Pinkernelle","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ejps.2022.106237_bib0082","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.bbi.2016.11.010","article-title":"Selective dentate gyrus disruption causes memory impairment at the early stage of experimental multiple sclerosis","volume":"60","author":"Planche","year":"2017","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.ejps.2022.106237_bib0083","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.yexcr.2004.01.002","article-title":"Interleukin-6 induces Alzheimer-type phosphorylation of tau protein by deregulating the cdk5\/p35 pathway","volume":"295","author":"Quintanilla","year":"2004","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.ejps.2022.106237_bib0084","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.msec.2017.08.012","article-title":"Hybrid nanofibers based on poly-caprolactone\/gelatin\/hydroxyapatite nanoparticles-loaded doxycycline: effective anti-tumoral and antibacterial activity","volume":"83","author":"Ram\u00edrez-Agudelo","year":"2018","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.ejps.2022.106237_bib0085","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1212\/01.wnl.0000201252.57661.e1","article-title":"A randomized, double-blind, futility clinical trial of creatine and minocycline in early Parkinson disease","volume":"66","author":"Ravina","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.ejps.2022.106237_bib0086","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1007\/s00702-019-02115-8","article-title":"Neuroprotection in Parkinson's disease: facts and hopes","volume":"127","author":"Salamon","year":"2020","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.ejps.2022.106237_bib0087","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s12640-015-9592-2","article-title":"Doxycycline suppresses microglial activation by inhibiting the p38 MAPK and NF-kB signaling pathways","volume":"29","author":"Santa-Cec\u00edlia","year":"2016","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.ejps.2022.106237_bib0088","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jaad.2005.10.004","article-title":"Tetracyclines: nonantibiotic properties and their clinical implications","volume":"54","author":"Sapadin","year":"2006","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.ejps.2022.106237_bib0089","doi-asserted-by":"crossref","first-page":"68","DOI":"10.3389\/fneur.2011.00068","article-title":"The promise of neuroprotective agents in Parkinson's disease","volume":"2","author":"Seidl","year":"2011","journal-title":"Front. Neurol."},{"key":"10.1016\/j.ejps.2022.106237_bib0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5114\/fn.2013.34190","article-title":"Molecular mechanisms of neuropathological changes in Alzheimer's disease: a review","volume":"51","author":"Ser\u00fd","year":"2013","journal-title":"Folia Neuropathol."},{"key":"10.1016\/j.ejps.2022.106237_bib0091","doi-asserted-by":"crossref","first-page":"2874","DOI":"10.1021\/acs.bioconjchem.7b00569","article-title":"Activated microglia targeting dendrimer-minocycline conjugate as therapeutics for neuroinflammation","volume":"28","author":"Sharma","year":"2017","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.ejps.2022.106237_bib0092","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/jcp.21306","article-title":"Exercise running and tetracycline as means to enhance skeletal muscle stem cell performance after external fixation","volume":"215","author":"Shefer","year":"2008","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.ejps.2022.106237_bib0093","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1001\/archderm.139.4.459","article-title":"Effects of subantimicrobial-dose doxycycline in the treatment of moderate acne","volume":"139","author":"Skidmore","year":"2003","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.ejps.2022.106237_bib0094","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/j.clinthera.2005.09.005","article-title":"Safety of doxycycline and minocycline: a systematic review","volume":"27","author":"Smith","year":"2005","journal-title":"Clin. Ther."},{"key":"10.1016\/j.ejps.2022.106237_bib0095","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.pneurobio.2017.12.002","article-title":"Exploiting the therapeutic potential of ready-to-use drugs: repurposing antibiotics against amyloid aggregation in neurodegenerative diseases","volume":"162","author":"Socias","year":"2018","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.ejps.2022.106237_bib0096","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1111\/ene.12953","article-title":"Minocycline added to subcutaneous interferon \u03b2-1a in multiple sclerosis: randomized RECYCLINE study","volume":"23","author":"S\u00f8rensen","year":"2016","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.ejps.2022.106237_bib0097","doi-asserted-by":"crossref","first-page":"4315","DOI":"10.1021\/pr300428e","article-title":"Minocycline effects on the cerebrospinal fluid proteome of experimental autoimmune encephalomyelitis rats","volume":"11","author":"Stoop","year":"2012","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.ejps.2022.106237_bib0098","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.biopsych.2010.06.012","article-title":"A meta-analysis of cytokines in Alzheimer's disease","volume":"68","author":"Swardfager","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.ejps.2022.106237_bib0099","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/jnc.12289","article-title":"Minocycline reduces remyelination by suppressing ciliary neurotrophic factor expression after cuprizone-induced demyelination","volume":"127","author":"Tanaka","year":"2013","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejps.2022.106237_bib0100","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/mds.10332","article-title":"Pathogenic role of glial cells in Parkinson's disease","volume":"18","author":"Teismann","year":"2003","journal-title":"Mov. Disord."},{"key":"10.1016\/j.ejps.2022.106237_bib0101","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurobiolaging.2017.06.018","article-title":"Novel UBQLN2 mutations linked to amyotrophic lateral sclerosis and atypical hereditary spastic paraplegia phenotype through defective HSP70-mediated proteolysis","volume":"58","author":"Teyssou","year":"2017","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.ejps.2022.106237_bib0102","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.2174\/092986707780597961","article-title":"Microglial activation and its implications in the brain diseases","volume":"14","author":"Thameem Dheen","year":"2007","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejps.2022.106237_bib0103","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1523\/JNEUROSCI.21-08-02580.2001","article-title":"Minocycline, a tetracycline derivative, is neuroprotective against excitotoxicity by inhibiting activation and proliferation of microglia","volume":"21","author":"Tikka","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejps.2022.106237_bib0104","article-title":"Advances in nanotechnology-based strategies for the treatments of amyotrophic lateral sclerosis","volume":"6","author":"Wang","year":"2020","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.ejps.2022.106237_bib0105","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1021\/acs.nanolett.8b04020","article-title":"Polysialic-acid-based micelles promote neural regeneration in spinal cord injury therapy","volume":"19","author":"Wang","year":"2019","journal-title":"Nano Lett."},{"key":"10.1016\/j.ejps.2022.106237_bib0106","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1080\/10717544.2017.1377315","article-title":"Brain targeted oral delivery of doxycycline hydrochloride encapsulated Tween 80 coated chitosan nanoparticles against ketamine induced psychosis: behavioral, biochemical, neurochemical and histological alterations in mice","volume":"24","author":"Yadav","year":"2017","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ejps.2022.106237_bib0107","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/jnr.10709","article-title":"Minocycline enhances MPTP toxicity to dopaminergic neurons","volume":"74","author":"Yang","year":"2003","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.ejps.2022.106237_bib0108","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1128\/AAC.28.2.347","article-title":"Penetration of oral doxycycline into the cerebrospinal fluid of patients with latent or neurosyphilis","volume":"28","author":"Yim","year":"1985","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejps.2022.106237_bib0109","doi-asserted-by":"crossref","first-page":"15769","DOI":"10.1073\/pnas.95.26.15769","article-title":"Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia","volume":"95","author":"Yrj\u00e4nheikki","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejps.2022.106237_bib0110","doi-asserted-by":"crossref","first-page":"13496","DOI":"10.1073\/pnas.96.23.13496","article-title":"A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window","volume":"96","author":"Yrj\u00e4nheikki","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejps.2022.106237_bib0111","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1177\/1352458506070319","article-title":"The clinical response to minocycline in multiple sclerosis is accompanied by beneficial immune changes: a pilot study","volume":"13","author":"Zabad","year":"2007","journal-title":"Mult. Scler."},{"key":"10.1016\/j.ejps.2022.106237_bib0112","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/ana.10476","article-title":"Additive neuroprotective effects of minocycline with creatine in a mouse model of ALS","volume":"53","author":"Zhang","year":"2003","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ejps.2022.106237_bib0113","doi-asserted-by":"crossref","DOI":"10.1088\/1758-5090\/7\/1\/015006","article-title":"Metal ion-assisted self-assembly of complexes for controlled and sustained release of minocycline for biomedical applications","volume":"7","author":"Zhang","year":"2015","journal-title":"Biofabrication"},{"key":"10.1016\/j.ejps.2022.106237_bib0114","article-title":"Ameliorating Alzheimer's-like pathology by minocycline via inhibiting Cdk5\/p25 signaling","author":"Zhao","year":"2021","journal-title":"Curr. Neuropharmacol."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098722001221?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098722001221?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T12:04:34Z","timestamp":1760529874000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098722001221"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":114,"alternative-id":["S0928098722001221"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2022.106237","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The potential use of tetracyclines in neurodegenerative diseases and the role of nano-based drug delivery systems","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2022.106237","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106237"}}